Study of the Safety, Tolerability and Immune Response of TBE Vaccines Administered to Healthy Children
Sponsor
Novartis (Industry)
Overall Status
Completed
CT.gov ID
NCT00311441
Collaborator
Novartis Vaccines (Industry)
300
1
Study Details
Study Description
Brief Summary
The purpose of this study is to evaluate the safety, immunogenicity and tolerability of TBE vaccines administered to children.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 4 |
Study Design
Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single
Primary Purpose:
Prevention
Official Title:
A Phase IV, Randomized, Controlled, Single-Blind, Multi-Center Study in Children to Evaluate the Safety, Tolerability and Immunogenicity of Two TBE Vaccines Administered According to Two Different Schedules.
Study Start Date
:
Mar 1, 2005
Outcome Measures
Primary Outcome Measures
- Immunogenicity of two pediatric TBE vaccines as measured by neutralization test and ELISA on days 28, 42, 300, and 321. []
Secondary Outcome Measures
- Tolerability of two paediatric TBE vaccines with respect to local and systemic reactions including fever []
Eligibility Criteria
Criteria
Ages Eligible for Study:
1 Year
to 10 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
- Healthy male and female children, 1 to 10 years of age.
Exclusion Criteria:
-
Subjects with documented evidence of TBE
-
Subjects, who have been previously vaccinated against TBE
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Weilheim | Germany |
Sponsors and Collaborators
- Novartis
- Novartis Vaccines
Investigators
- Study Director: Drug Information Services, Novartis Vaccines & Diagnostics
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00311441
Other Study ID Numbers:
- M48P3
- 911
First Posted:
Apr 6, 2006
Last Update Posted:
Mar 17, 2008
Last Verified:
Mar 1, 2008
Keywords provided by ,
,
Additional relevant MeSH terms: